6-Heteroaryloxy Benzimidazoles and Azabenzimidazoles as JAK2 Inhibitors
Copyright © Targeted News Service, 2024
2024-07-23
Copyright © Targeted News Service, 2024
2024-07-23
ALEXANDRIA, Virginia, July 23 -- AJAX THERAPEUTICS, INC., New York, New York has been assigned a patent (No. US 12043632 B2, initially filed Dec. 22, 2021) developed by seven inventors Craig E. Masse, Cambridge, Massachusetts; Jeremy R. Greenwood, Brooklyn, New York; Sayan Mondal, New York, New York; Jiayi Xu, Marlboro, New Jersey; Phani Ghanakota, Edison, New Jersey; Fiona Michelle McRobb, Brooklyn, New York; and Nicholas Boyles, Hillsboro, Oregon, for "6-heteroaryloxy benzimidazoles and azabe . . .